Lyme, CT, United States of America

James J Cawley


Average Co-Inventor Count = 2.4

ph-index = 1


Company Filing History:


Years Active: 2002-2004

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovative Mind of James J. Cawley

Introduction

James J. Cawley, an accomplished inventor residing in Lyme, Connecticut, has significantly contributed to the field of microbial biotechnology. With two notable patents to his name, he is recognized for his inventive techniques that process bicyclic heteroaromatic compounds. His work demonstrates a profound understanding of microbial processes, aiming to harness these for practical applications.

Latest Patents

Cawley's latest patents reflect his focus on microbial oxidation processes. The first patent, titled "Microbial conversion of bicyclic heteroaromatic compounds," outlines a method that involves contacting these compounds with a microorganism and incubating the mixture under specific conditions. This innovative process ultimately yields carboxylic acids, which can be further isolated and purified.

His second patent, "Microbial conversion of 2-methylquinoxaline," presents a process for oxidizing 2-methylquinoxaline into 2-quinoxalinecarboxylic acid. Similar to his first invention, this process also involves the use of microorganisms and conditions conducive to producing the desired product, which can subsequently be isolated and purified as well.

Career Highlights

James J. Cawley is associated with Pfizer Corporation, where he has been able to apply his expertise in biotechnology to develop scientific advancements. His role at Pfizer has allowed him to contribute to significant innovations in the pharmaceutical field.

Collaborations

Throughout his career, Cawley has collaborated with notable colleagues, including John Wing Wong and Michael P. Burns. These partnerships have fostered an environment of innovation and creativity, enabling him to push the boundaries of microbial application processes.

Conclusion

James J. Cawley embodies the spirit of innovation through his inventive contributions to the microbial conversion processes. With a focus on practical applications of microbial technology, his patents not only reflect his ingenuity but also highlight the potential for future advancements in the field. As Cawley continues his work at Pfizer Corporation, the scientific community eagerly anticipates his next contribution to biotechnology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…